Jenny Barnett
Algemeen Directeur bij Monument Therapeutics Ltd.
Actieve functies van Jenny Barnett
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Monument Therapeutics Ltd.
Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Monument Therapeutics Ltd. is a British UK-based biotechnology company that focuses on bringing precision medicine to neuroscience drug development. The company is based in Bottisham, UK, and was founded in 2019. The company was formed as a spin-out from Cognition and has a mission to use precision medicine to develop therapeutic products for patients with substantial central nervous system indications and significant unmet medical needs. Monument Tx has a well-balanced pipeline that includes two lead programs, and proprietary biomarkers developed by the team allow for precise selection of patients most likely to benefit from treatment. The therapeutic products under development are novel formulations utilizing well-characterized technology. Jenny Barnett has been the CEO of the company since 2019. | Algemeen Directeur | 01-01-2019 | - |
Loopbaan van Jenny Barnett
Eerdere bekende functies van Jenny Barnett
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CAMBRIDGE COGNITION HOLDINGS PLC | Hoofd Techniek/Wetenschap/O&O | - | 01-04-2022 |
Cambridge Cognition Ltd.
Cambridge Cognition Ltd. Packaged SoftwareTechnology Services Cambridge Cognition Ltd. operates as a neuroscience technology company delivering near-patient assessment solutions to improve the understanding, diagnosis and treatment of neurological and psychiatric disorders. It offers CANTAB Tests and Services, CANTAB mobile and CANTABeclipse. The company was founded in 2002 and is headquartered in Cambridge, GB. | Hoofd Techniek/Wetenschap/O&O | 01-01-2008 | 03-05-2013 |
Corporate Officer/Principal | 03-05-2013 | - |
Statistieken
Internationaal
Verenigd Koninkrijk | 4 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sectoraal
Technology Services | 3 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CAMBRIDGE COGNITION HOLDINGS PLC | Technology Services |
Bedrijven in privébezit | 2 |
---|---|
Cambridge Cognition Ltd.
Cambridge Cognition Ltd. Packaged SoftwareTechnology Services Cambridge Cognition Ltd. operates as a neuroscience technology company delivering near-patient assessment solutions to improve the understanding, diagnosis and treatment of neurological and psychiatric disorders. It offers CANTAB Tests and Services, CANTAB mobile and CANTABeclipse. The company was founded in 2002 and is headquartered in Cambridge, GB. | Technology Services |
Monument Therapeutics Ltd.
Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Monument Therapeutics Ltd. is a British UK-based biotechnology company that focuses on bringing precision medicine to neuroscience drug development. The company is based in Bottisham, UK, and was founded in 2019. The company was formed as a spin-out from Cognition and has a mission to use precision medicine to develop therapeutic products for patients with substantial central nervous system indications and significant unmet medical needs. Monument Tx has a well-balanced pipeline that includes two lead programs, and proprietary biomarkers developed by the team allow for precise selection of patients most likely to benefit from treatment. The therapeutic products under development are novel formulations utilizing well-characterized technology. Jenny Barnett has been the CEO of the company since 2019. | Health Technology |
- Beurs
- Insiders
- Jenny Barnett
- Ervaring